Purchase Order N3239825P0714
- Not listed
- Haemonetics Corporation has been awarded a $99,768 firm fixed-price purchase order by the Defense Health Agency for annual preventative maintenance services on hemostasis analyzer systems at Brooke Army Medical Center in Fort Sam Houston, Texas. This contract, awarded October 1, 2024, represents the exercise of Option 1 under an existing agreement and extends through September 30, 2027. The Defense Health Agency, which operates under the Department of Defense, maintains medical facilities and...
- The U.S. Defense Health Agency awarded a Firm Fixed Price purchase order contract to Haemonetics Corporation, a leading medical technology company, for the provision of HAEMONETICS EQUIPMENT SERVICE MAINT. The $69,732.00 contract has a period of performance through September 30, 2027. Haemonetics, a for-profit organization registered in SAM.gov since 2002, specializes in blood and plasma management products and services. This contract does not have a set-aside designation, indicating...
- Haemonetics Corporation has been awarded a firm fixed price purchase order contract valued at approximately $22,836 by the Department of Health and Human Services National Institutes of Health Clinical Center. This one-year maintenance agreement is needed by the Department of Laboratory Medicine to support TEG 5000 instruments and will be performed in Bethesda, Maryland. No set-aside designation was applied to this solicitation. Haemonetics Corporation will serve as the prime contractor to...
- This is a firm-fixed price purchase order contract awarded to Haemonetics Corporation, doing business as Haemonetics, by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense. The contract, valued at $37,151.60, is for a TEG Platinum Premium Service contract to provide maintenance and support services for TEG (Thromboelastography) hemostasis analyzers. The contract does not have a set-aside designation and runs through July 31, 2025. Haemonetics is a leading...
- This is a $9,000.00 firm fixed price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Haemonetics Corporation for a maintenance service agreement for laboratory analyzers and blood gas equipment. The contract was awarded on August 21, 2013 with a period of performance through August 22, 2016. This contract does not have a set-aside designation, reflecting Haemonetics' status as a large, established provider of medical...
- The federal contract award HT940623P0100, valued at $91,029.00, was issued by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading medical technology company, for the provision of implementation services. This is a firm-fixed-price purchase order contract with no set-aside designation, indicating Haemonetics' competitiveness as a large, established provider of specialized medical equipment and services to government healthcare agencies. The contract includes the supply of...
- This federal contract award is for the maintenance of HAEMONETICS ACP 215 equipment, awarded by the Department of the Army Medical Command to the prime contractor Haemonetics Corporation, doing business as Haemonetics. The single award, firm fixed price purchase order has a potential value of $150,400.00 and a completion date of September 30, 2022. Haemonetics is a provider of blood and plasma supplies and services, offering devices and consumables for blood collection, processing, and...
- The Defense Health Agency awarded a $39,282.35 firm fixed-price purchase order to Haemonetics Corporation for hemostasis supplies. The award, issued on August 8, 2025, with an ultimate completion date of August 8, 2025, represents a straightforward procurement with no set-aside designation, indicating open and competitive bidding. Performance will take place in Bethesda, Maryland. Haemonetics, a Boston-based medical technology leader, specializes in blood and plasma management products and is...
- This $67,003.20 firm-fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Haemonetics Corporation, a leading provider of blood and plasma management products and services. The contract does not have a set-aside designation. The award is for the delivery of 0236-00 items as described in the contract, likely blood processing equipment and consumables. Haemonetics is an established medical device manufacturer that has received...
- This federal contract award is for the calibration of three TEG 5000 Analyzers. The contract was awarded by the Bureau of Medicine and Surgery, which is a defense agency, to the prime contractor Haemonetics Corporation. The contract has a firm fixed price of $4,785.91 and was awarded on June 13, 2017, with a completion date of August 9, 2018. The contract does not have a set-aside designation. Haemonetics Corporation is a leading provider of blood and plasma management products and services to...
Haemonetics Corporation has been awarded a $88,770 firm fixed-price purchase order by the Bureau of Medicine and Surgery to provide annual maintenance services for three TEG 5000 hemostasis analyzers at the Naval Medical Research Unit in San Antonio, Texas. The contract, effective September 30, 2025, extends through September 30, 2030, and covers preventive and corrective maintenance for the specified devices to ensure continued operational capability for clinical hemostasis testing and research applications. This award was made on a competitive basis with no set-aside designation, reflecting Haemonetics' established position as a primary vendor of advanced medical technology and maintenance services to Department of Defense healthcare facilities. The Naval Medical Research Unit, San Antonio serves as a critical research and clinical support organization within the Defense Health Agency network, and the maintenance agreement ensures that laboratory equipment supporting surgical, transfusion, and hemostasis management remains fully operational. Haemonetics' comprehensive federal contracting presence, including a significant Indefinite Delivery Contract valued at over $3.8 million with the Department of Veterans Affairs for autotransfusion units and related equipment, demonstrates the company's substantial role in supporting blood and plasma management capabilities across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | $0 | 9/2/25 |